Increasing efficiency in vaccine Production: A primer for change

Area of Science:

• Public Health
• Vaccinology
• Global Health Equity

Background:

• The COVID-19 pandemic underscored the critical role of vaccines in public health and pandemic preparedness.
• Significant delays persist in introducing vaccines at scale in low-income countries compared to high-income nations.
• Challenges include intellectual property protection, rigorous regulatory oversight, manufacturing know-how transfer, and market dynamics.

Purpose of the Study:

• To examine the vaccine research and development (R&D) process.
• To identify systemic reforms that can accelerate vaccine introduction in low and middle-income countries (LMICs).
• To address long-standing issues of equitable vaccine distribution and reliable supply.

Main Methods:

• Review of the existing vaccine development and introduction ecosystem.
• Analysis of challenges impacting timely vaccine scale-up in LMICs.
• Exploration of potential reform opportunities within the R&D framework.

Main Results:

• Identified multifaceted barriers to vaccine access in LMICs, including IP, regulatory, manufacturing, and market-related obstacles.
• Highlighted that delays in vaccine introduction are a persistent global health challenge.
• Recognized opportunities for system-level improvements to enhance global vaccine accessibility.

Conclusions:

• Reforming the vaccine R&D and supply chain system is crucial for improving global health equity.
• Accelerating vaccine introduction in LMICs requires addressing complex challenges in IP, regulation, and manufacturing.
• Systemic changes can enhance pandemic preparedness and ensure broader access to essential vaccines.